These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3009987)

  • 21. Unoccupied nuclear oestradiol-receptor sites in normal human endometrium.
    Lévy C; Mortel R; Eychenne B; Robel P; Baulieu EE
    Biochem J; 1980 Mar; 185(3):733-8. PubMed ID: 6992771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding.
    Migliaccio A; Di Domenico M; Green S; de Falco A; Kajtaniak EL; Blasi F; Chambon P; Auricchio F
    Mol Endocrinol; 1989 Jul; 3(7):1061-9. PubMed ID: 2797002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-specific dephosphorylation of smooth muscle myosin light chain kinase by protein phosphatases 1 and 2A.
    Nomura M; Stull JT; Kamm KE; Mumby MC
    Biochemistry; 1992 Dec; 31(47):11915-20. PubMed ID: 1332778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro inactivation of oestrogen receptor by nuclei: prevention by phosphatase inhibitors.
    Auricchio F; Migliaccio A
    FEBS Lett; 1980 Aug; 117(1):224-6. PubMed ID: 6250893
    [No Abstract]   [Full Text] [Related]  

  • 25. Phosphorylation of purified estradiol-liganded estrogen receptor by casein kinase II increases estrogen response element binding but does not alter ligand stability.
    Tzeng DZ; Klinge CM
    Biochem Biophys Res Commun; 1996 Jun; 223(3):554-60. PubMed ID: 8687434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oestradiol and testosterone binding sites in mice tibiae and their relationship with bone growth.
    Lopez A; Ventanas J; Burgos J
    Exp Clin Endocrinol; 1986 Nov; 88(1):31-8. PubMed ID: 3817001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of monoclonal antibodies to the nuclear estrogen receptor in intact nuclei.
    Moncharmont B; Parikh I
    Biochem Biophys Res Commun; 1983 Jul; 114(1):107-12. PubMed ID: 6882416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific binding of oestradiol to guinea-pig prostate cytosol and nuclear fractions.
    Tilley WD; Horsfall DJ; Cant EL; Marshall VR
    J Steroid Biochem; 1985 Jun; 22(6):705-11. PubMed ID: 4021477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estradiol regulation of uterine nucleolar estradiol binding sites.
    Whelly SM
    Biochim Biophys Acta; 1986 Feb; 880(2-3):179-88. PubMed ID: 2417631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biochemical mechanisms of the stimulating action of estradiol on the growth of mammary tumours.
    Morozova TM; Mitina RL; Nagibneva IN; Ozhogina ZB; Salganik RI
    Exp Clin Endocrinol; 1986 Dec; 88(3):293-302. PubMed ID: 3030784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of calf uterus estradiol receptor with erythrocyte cytoskeleton.
    Puca GA; Nola E; Molinari AM; Armetta I; Sica V
    J Steroid Biochem; 1981 Dec; 15():307-12. PubMed ID: 7339257
    [No Abstract]   [Full Text] [Related]  

  • 32. Acceptor sites for the oestrogen receptor in hen oviduct chromatin.
    Ruh TS; Spelsberg TC
    Biochem J; 1983 Mar; 210(3):905-12. PubMed ID: 6870810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of smooth muscle contractile proteins by calmodulin and cyclic AMP.
    Adelstein RS; Sellers JR; Conti MA; Pato MD; de Lanerolle P
    Fed Proc; 1982 Oct; 41(12):2873-8. PubMed ID: 6290274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of estradiol receptor on tyrosine and interaction of estradiol and glucocorticoid receptors with antiphosphotyrosine antibodies.
    Auricchio F; Migliaccio A; Castoria G; Rotondi A; Di Domenico M; Pagano M; Nola E
    Adv Exp Med Biol; 1988; 231():519-40. PubMed ID: 2458018
    [No Abstract]   [Full Text] [Related]  

  • 35. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
    Migliaccio A; Di Domenico M; Castoria G; de Falco A; Bontempo P; Nola E; Auricchio F
    EMBO J; 1996 Mar; 15(6):1292-300. PubMed ID: 8635462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro effects of cytosolic inhibitor and opiates on the binding of [3H]oestradiol to nuclear type II binding sites of rat uterus and hypothalamus.
    Garai J; Vértes M; Kovács S
    J Steroid Biochem; 1989 Mar; 32(3):433-8. PubMed ID: 2704239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptors for oestradiol in human placenta.
    Laminski NA; Hammond KD
    Placenta; 1985; 6(5):383-9. PubMed ID: 4070180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes.
    Pietras RJ; Szego CM
    Biochem J; 1980 Dec; 191(3):743-60. PubMed ID: 7283971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.